We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Rules FDA Wrongly Approved Jacobus Pharmaceuticals Drug
Appeals Court Rules FDA Wrongly Approved Jacobus Pharmaceuticals Drug
A federal appeals court has ruled that the FDA incorrectly approved a rare disease drug from Jacobus Pharmaceuticals because Catalyst Pharmaceuticals already owned the rights to the drug.